← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2013Last known activity
Feb 6, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06765161OfficialPhase 3Feb 6, 2025
- NCT06765161Lead sponsorPhase 3Feb 6, 2025
- NCT06765161Sponsor investigatorPhase 3Feb 6, 2025
- NCT03047473Lead sponsorPhase 2Mar 10, 2017
- NCT03047473Reponsible party - principal investigatorPhase 2Mar 10, 2017
- NCT02146534Overall official - principal investigatorPhase 4Dec 1, 2013
- NCT02146534Lead sponsorPhase 4Dec 1, 2013
Details
- Last known activity
- Feb 6, 2025